SMALL CELL CARCINOMA AND SMALL CELL CARCINOMA PATHOLOGY OUTLINES

 

small cell carcinoma:

Small cell lung cancer, also known as small cell carcinoma, is a type of lung cancer that is characterized by the small size of the cancer cells. Small cell lung cancer is an aggressive and fast-growing cancer that typically starts in the bronchi, the larger airways of the lungs. It can also spread quickly to other parts of the body, such as the brain, liver, and bones.

Small cell lung cancer is strongly associated with smoking, and it is estimated that around 80-85% of cases of small cell lung cancer are caused by smoking. However, other risk factors include exposure to radon gas, air pollution, and exposure to asbestos.

Symptoms of small cell lung cancer can include shortness of breath, cough, chest pain, hoarseness, and weight loss. The symptoms may not be noticeable in the early stages of the cancer, and the diagnosis may not be made until the cancer has advanced.

Treatment options for small cell lung cancer include surgery, radiation therapy, and chemotherapy. In some cases, a combination of treatments may be used. However, the effectiveness of treatment depends on the stage of the cancer at the time of diagnosis and the overall health of the patient.

The prognosis for small cell lung cancer is generally poor, with most cases being diagnosed at an advanced stage and the average survival time being around 12-18 months. However, some patients may live for several years with the disease.

In summary, small cell lung cancer, also known as small cell carcinoma, is a type of lung cancer characterized by the small size of the cancer cells, and it is an aggressive and fast-growing cancer.

small cell carcinoma pathology outlines

Small cell lung cancer, also known as small cell carcinoma, is a type of lung cancer that is characterized by the small size of the cancer cells. It is an aggressive and fast-growing cancer that typically starts in the bronchi, the larger airways of the lungs.

Pathologically, small cell lung cancer is classified as a neuroendocrine tumor and is characterized by the presence of small, round cells that have a high nuclear-to-cytoplasmic ratio and hyperchromatic nuclei. It is also characterized by a high mitotic index and the presence of neurosecretory granules in the cytoplasm.

Small cell lung cancer is strongly associated with smoking, and it is estimated that around 80-85% of cases of small cell lung cancer are caused by smoking. However, other risk factors include exposure to radon gas, air pollution, and exposure to asbestos.

The diagnosis of small cell lung cancer is typically made through a combination of imaging studies, such as a chest X-ray or CT scan, and a biopsy of the tumor.

Treatment options for small cell lung cancer include surgery, radiation therapy, and chemotherapy. In some cases, a combination of treatments may be used. The chemotherapy regimen most commonly used is called cisplatin and etoposide, and radiation therapy is often used in conjunction with chemotherapy.

The prognosis for small cell lung cancer is generally poor, with most cases being diagnosed at an advanced stage and the average survival time being around 12-18 months. The 5-year survival rate for small cell lung cancer is typically around 5-10%. However, some patients may live for several years with the disease, especially if the cancer is diagnosed at an early stage and if the patient responds well to treatment.

In summary, small cell lung cancer, also known as small cell carcinoma, is a type of lung cancer characterized by the small size of the cancer cells and it is an aggressive and fast-growing cancer. It is strongly associated with smoking, and the diagnosis is typically made through a combination of imaging studies and a biopsy of the tumor. The treatment options include surgery, radiation therapy, and chemotherapy. The prognosis is generally poor, with most cases being diagnosed at an advanced stage and the average survival time being around 12-18 months.